Your browser doesn't support javascript.
loading
G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway.
Qiao, Hai-Feng; Liu, Ying-Lei; You, Jun; Zheng, Yan-Li; Chen, Li-Ping; Lu, Xiao-Yan; Du, Lei; Shan, Feng; Liu, Man-Hua.
Afiliação
  • Qiao HF; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. Electronic address: j9043j@jczye.com.
  • Liu YL; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. Electronic address: 7dgbii@jczye.com.
  • You J; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. Electronic address: 6nriph@jczye.com.
  • Zheng YL; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. Electronic address: hbu434@jczye.com.
  • Chen LP; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. Electronic address: dpydqj@jczye.com.
  • Lu XY; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. Electronic address: ytaxc7@jczye.com.
  • Du L; Department of Medical Laboratory, The First Affiliated Hospital of Xi'an Jiaotong University, China. Electronic address: x2evpn@jczye.com.
  • Shan F; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China. Electronic address: 2817kx@jczye.com.
  • Liu MH; Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, 226001, China. Electronic address: liumanhua622@163.com.
J Reprod Immunol ; 140: 103129, 2020 08.
Article em En | MEDLINE | ID: mdl-32334286

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Piridonas / Cisplatino / MicroRNAs / Carcinoma Epitelial do Ovário Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Piridonas / Cisplatino / MicroRNAs / Carcinoma Epitelial do Ovário Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article